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The main goal of this work was to develop a strategy to identify B-cell epitopes on four different three
ﬁnger toxins (3FTX) and one phospholipase A2 (PLA2) from Micrurus corallinus snake venom. 3FTx and
PLA2 are highly abundant components in Elapidic venoms and are the major responsibles for the toxicity
observed in envenomation by coral snakes. Overlapping peptides from the sequence of each toxin were
prepared by SPOT method and three different anti-elapidic sera were used to map the epitopes. After
immunogenicity analysis of the spot-reactive peptides by EPITOPIA, a computational method, nine se-
quences from the ﬁve toxins were chemically synthesized and antigenically and immunogenically
characterized. All the peptides were used together as immunogens in rabbits, delivered with Freund's
adjuvant for a ﬁrst cycle of immunization and Montanide in the second. A good antibody response
against individual synthetic peptides and M. corallinus venomwas achieved. Anti-peptide IgGs were also
cross-reactive againstMicrurus frontalis andMicrurus lemniscatus crude venoms. In addition, anti-peptide
IgGs inhibits the lethal and phospholipasic activities of M. corallinus crude venom. Our results provide a
rational basis to the identiﬁcation of neutralizing epitopes on coral snake toxins and show that their
corresponding synthetic peptides could improve the generation of immuno-therapeutics. The use of
synthetic peptide for immunization is a reasonable approach, since it enables poly-speciﬁcity, low risk of
toxic effects and large scale production.
© 2014 Elsevier Ltd. All rights reserved.1. Introduction
In South-East Brazil, human envenomation by snakes from the
Elapidae family is caused mainly by Micrurus corallinus and
Micrurus frontalis, popularly known as “coral snakes” (Le~ao et al.,
2009). The incidence of ophidic accidents with coral snakes is
smaller when compared to other snake genera. However, due to the
wide geographic dispersion of Micrurus and the severity of the
accident, the local Ministry of Health has to assure that the speciﬁc
antivenom is distributed all over the country (Brasil, Ministerio da
Saúde 2014).ica e Imunologia, Instituto de
erais, Belo Horizonte, Brazil.
lortegui).The transcriptome proﬁle ofM. corallinus venom glands provided
a comprehensive view of Elapidae toxins. Three-Finger toxins
(3FTx) and phospholipase A2 (PLA2) toxins correspond to the major
toxin transcripts (Le~ao et al., 2009). 3FTx are small neurotoxic
proteins with distinct pharmacological effects, but are generally
associated with post-synaptic blockage (Utkin, 2013). PLA2 are
ubiquitous enzymes in snake venoms and can be pre-synaptic or b-
neurotoxins with speciﬁc targets, inhibiting the release of neuro-
mediators (Kini, 2003). Some other toxins from this family may act
like myotoxin, depolarizing muscle cell membranes, leading to
necrosis (Mebs and Ownby, 1990).
The parenteral administration of anti-venoms constitutes the
mainstay in snakebite envenoming therapy. Two commercial anti-
elapidic anti-venoms are available from the Brazilian Ministry of
Health and are produced by Instituto Butantan (IB), S~ao Paulo,
Brazil and by Fundaç~ao Ezequiel Dias (FUNED) of the State of Minas
Gerais, Brazil. Both of them are bivalent anti-elapidic venom sera,
obtained by the immunization of horses with a deﬁned mixture of
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neutralize efﬁciently the lethal activity of these two species (Prieto
da Silva et al., 2001).
The immunization of horses or other animals for anti-venom
production with crude venoms or recombinant toxic analogues is
a difﬁcult task, due to the highly lethal or toxic character of the
immunogens. To cope with this, the use of synthetic non-toxic
peptides can be an alternative approach to generate serum or
vaccines against toxins. In fact, the use of synthetic peptides, cor-
responding to deﬁned parts of the amino acid sequence (epitopes)
of certain toxins can actually lead to anti-venom preparation
(Alvarenga et al., 2002; Felicori et al., 2010).
In the present study, overlapping pentadecapeptides covering
the complete amino acid sequence of four 3FTx and one repre-
sentative of PLA2 toxins fromM. corallinus venom was prepared by
SPOT synthesis (Laune et al., 2002). To identify linear B-cell epi-
topes in the selected toxins, immunoassays of the synthetic pep-
tides probed with either rabbit antibodies anti-M. corallinus crude
venom, or with horse antibodies present in therapeutic anti-
venoms were performed. We found that several of these peptides
bound to anti-M. corallinus antibodies. Synthetic replicas of the
most reactive peptides were used as immunogens in rabbits. The
immunization process induced antibodies that were able to
neutralize the phospholipase activity of M. corallinus crude venom,
as well as its lethality.
2. Materials and methods
2.1. Animals and venoms
M. corallinus, M. frontalis and Micrurus lemniscatus, venoms
samples were kindly provided by FUNED. The lyophilized samples
were stored ad 20 C in the dark until use.
Female Swiss mice (18e22 g) and New Zealand female rabbits
(2 kg) were maintained in the Centro de Bioterismo of Instituto de
Cie^ncias Biologicas of Universidade Federal de Minas Gerais
(UFMG), Brazil. All animals received food and water ad libitum
under controlled environmental conditions. The experimental
protocols were performed after approval by the Ethics Committee
in animal Experimentation (protocol 375/2012-CETEA/UFMG).
2.2. Identiﬁcation of cell-B epitopes
2.2.1. Peptide synthesis on cellulose membranes
Overlapping pentadecapeptides (15-mer), frameshifted by three
residues, covering the amino acid sequences of four M. corallinus
three ﬁnger toxins (3FTX): Mcor100c (GenBank: ACS74997.1),
Mcor0039c (GenBank: ACS74994.1), Mcor0064c (GenBank:
AF197565_1), MCcor599c (GenBank: NXAH8_MICCO) and of one
phospolipase A2 (PLA2) (McorPLA2 GenBank: AAN60018) (Le~ao
et al. 2009), were prepared using the SPOT technique (Frank,
2002), following the protocol of Laune et al., 2002. The cellulose
membranes were obtained from Intavis (Koln, Germany); ﬂuo-
renylmethyloxycarbonyl amino acids and N-hydroxybenzotriazole
were from Novabiochem. A Multipep ResPep SL Automatic Spot
synthesizer (IntavisAG, Bioanalytical Instruments, Germany) was
used for the automated peptide synthesis in the membrane. After
the peptide sequences were assembled, the side-chain protecting
groups were removed by treatment with triﬂuoroacetic acid.
2.2.2. Immunoassay with cellulose-bound peptides
After an overnight saturation step with 3% BSA, the set of
membrane bound peptides was probed by incubation with either
one of the two Brazilian divalent antielapidic sera (produced at
FUNED and IB) or with rabbit serum anti-M. corallinus crudevenom. Antibody binding was detected by using the alkalin-
eephosphatase conjugated anti-horse or anti-rabbit antibody
(Sigma, diluted 1:2000; 90 min, 37 C). After washing, the phos-
phatase substrate 5-bromo-4-chloro-3-indolyl phosphate (Sigma)
and 3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyltetrazolium bromide
(Sigma) were added. A blue precipitate was observed over the spots
containing the peptides that reactedwith the tested antibodies. The
membrane was placed on a color scanner and scanned without
scale reduction. A plot of spot intensities was obtained with the
ImageJ software. To allow the reuse of the membrane, it was
sequentially treated with dimethylformamide, 1% SDS, 0.1% 2-
mercaptoethanol in 8 M urea, ethanol/water/acetic acid (50:40:10
vol/vol/vol) and, ﬁnally, ethanol, to remove the precipitated dye
and molecules bound to the peptides.
2.2.3. Immunogenicity analysis of identiﬁed epitopes
In order to predict the immunogenic potential of the tested
toxins sequence residues, the EPITOPIA serverwas used (Rubinstein
et al., 2009). The sequences that showed high reactivity with the
three tested sera by the SPOT method and the residues that ob-
tained the highest score by EPITOPIA were analyzed in order to
choose regions of maximum 20 residues to be synthesized in sol-
uble form and to be used as immunogens.
2.2.4. Molecular modeling and epitope localization
The localization of the chosen peptides were analyzed within
the three dimensional modeled structures of the M. corallinus
toxins. The three dimensional models of the toxins were obtained
based on a homology modeling, using the Swiss Model tool (Arnold
et al., 2006).
2.3. Synthesis of soluble peptides
Based on the analysis of the results with the cellulose-bound
peptides and the immunogenicity prediction, the following se-
quences were chosen to be synthesized in the soluble form using
the F-moc chemistry: 39PDDFTCVKKWEGGGRRV55, from the 3FTX
Mcor 0100c, named Pep100, 37TCPAGQKICFKKWKKG52 and
64PKPKKDETIQCCTKNN79, from 3FTX Mcor0039c, named Pep039a
and Pep039b respectively, 22LECKICNFKTCPTDELRH39 and 54THRGL
RIDRGCAATCPTVK72 from 3FTX Mcor0604c, named Pep604a and
Pep604b,28RHASDSQTTTCLSGICYKK45 and 58GCPQSSRGVKVDCCM
RDK75, fromMcor0599c, named Pep599a and Pep599b respectively
and the peptides 28NLINFQRMIQCTTRRSAW45 and 119NCDRTAAL
CFGRAPYNKNN137, from McorPLA2, named PepPLA2a and Pep-
PLA2b. All the internal cysteine residues were replaced by serine,
and a tyrosine was added to the n-terminus of the sequences which
did not possess aromatic residues (Pep039b, Pep604a and b and
Pep599b), to allow quantiﬁcation of the peptides by absorbance at
280 nm. After the synthesis, the peptides were lyophilized and their
purity was assessed by mass spectrometry in system MALDI-TOF/
TOF (Autoﬂex III e Bruker Daltonics Inc.).
2.3.1. Glutaraldehyde peptide polymerization
To increase the binding of peptides to ELISA plates, the selected
soluble peptides were polymerized, using glutaraldehyde as a
cross-linker, according to Machado-de-Avila et al. (2004), with
modiﬁcations. Brieﬂy, 10 mg of each peptide was diluted in 1 ml of
PBS. One ml of a 1% glutaraldehyde solution was added to each
peptide mixture at 4 C and kept under constant agitation for 1 h.
The reaction was allowed to proceed further for 1 h at 4 C, and the
free aldehyde coupling groups and the intermediates were reduced
by the addition of NaBH4(10 mg/ml). At the end of the reaction, the
excess of NaBH4 and any non-covalently coupled synthetic peptide
was removed from the mixture by dialyzing it extensively against
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stored at 20 C until use and used only for the ELISA assays.
2.4. Immunization protocols
Adult New Zealand female rabbits were immunized with anti-
M. corallinus venom, in order to obtain speciﬁc antibodies to map
epitopes using the toxin-derived membrane bound peptides. After
collection of pre-immune sera, the animals received an initial
subcutaneous injection of 250 mg of M. corallinus crude venom in
complete Freund's adjuvant (day 1). Five booster injections were
made subcutaneously at intervals of twoweeks with the same dose
(250 mg) in incomplete Freund's adjuvant. For the production of
anti-peptide antibodies, the rabbits received subcutaneously an
initial injection of 450 mg of the mixture of all peptides (50 mg of
each peptide) in complete Freund's adjuvant. Five subcutaneous
booster injections of the same dose in incomplete Freund's adju-
vant and PBS were made, at intervals of two weeks. Blood samples
werewithdrawn oneweek after each injection. After a break of two
months, the rabbits received six additional doses of 450 mg of the
mixture of all peptides in Montanide adjuvant at intervals of two
weeks. Blood samples were withdrawn one week after each
injection.
For the neutralization of PLA2 activity, IgGs were puriﬁed from
rabbit's sera. IgGs anti-M. corallinus crude venom or anti-peptides
in immunized rabbit sera were concentrated by precipitation us-
ing ammonium sulfate, and puriﬁed by afﬁnity chromatography
using a Protein A-Sepharose column (GE Healthcare), according to
the protocol described by the GE Healthcare Bio-Sciences AB.
2.5. Indirect ELISA assays
Maxisorp microtitration plates (Nalge Nunc, USA) were coated
overnight at 4 C with 100 ml of a 5 mg/ml solution of venom
(M. corallinus, M. frontalis, M. lemniscatus) or glutaraldehyde-
polimerized peptides (10 mg/ml solution) in carbonate buffer pH
9.6. After blocking (3% skimmed milk in PBS) and washing (0.05%
Tween-saline), sera from pre-immune and immune rabbit or pu-
riﬁed IgGs were added in different dilutions and incubated for 1 h
at 37 C. Plates were washed and incubated with anti-rabbit IgG
conjugated with peroxidase (Sigma, USA) diluted 1:6000, for 1 h at
37 C. After washing, 100 ml of o-phenylenediamine (0.33 mg/ml in
citrate buffer, pH 5.2, in the presence of 0.04% hydrogen peroxide)
was added to the wells. The reaction was interrupted after 30 min
by the addition of 20 ml of a 1:20 sulfuric acid solution. Absorbance
values were determined at 490 nm using an ELISA plate reader
(BIO-RAD, 680 models, EUA). The assays were made in duplicates
and the means were calculated.
2.6. Neutralization assays
2.6.1. Neutralization of phospholipase activity
The PLA2 activity was determined using an indirect hemolytic
assay described by Gutierrez et al. (1988). Increasing concentra-
tions of M. corallinus crude venomwere prepared in a ﬁnal volume
of 15 ml in PBS and added to 3 mm wells in agarose gels (0.8% in
phosphate buffered saline, pH 8.1) containing 1.2% rabbit erythro-
cytes, 1.2% egg yolk as a lecithin source and 100 mM of CaCl2. After
incubation at 37 C for 18 h in a wet chamber, the hemolytic halos
were measured. After the determination of the minimum phos-
pholipasic dose (MPD: the minimum concentration of venom
which produced a hemolytic halo of 1 cm of diameter), the property
of rabbits IgG's anti-peptides to neutralize 1 MPD was tested.
Increasing concentration of IgGs were pre-incubated with 1 MPD at
37 C for 1 h and added to the 3 mm wells in agarose. Afterincubation at 37 C for 18 h in a wet chamber, the hemolytic halos
weremeasured. As controls, pre-immune IgGs were incubatedwith
venom (Cþ) and a pool of IgG was incubated with PBS (C).
2.6.2. Neutralization of lethal activity
For the in vivo neutralization assays, 3 groups of 4 mice were
used. Each mice received intra-peritoneally 500 ml of a solution
containing a dose corresponding to 1.5 LD50 ofM. corallinus venom
(Tanaka et al., 2010) in PBS-BSA 0.1%, pre-incubated for 1 h at 37 C
with either with 100 ml of anti-elapidic sera (FUNED) (Group 1),
100 ml of a pool of sera from the rabbits immunized with peptides
(Group 2) or 100 ml of PBS (Group 3). Deaths were counted 48 h
after the challenge.
3. Results
3.1. Identiﬁcation of B cell epitopes
The ﬁrst step for epitope localization in the two major toxins
classes (3FTx and PLA2) of M. corallinus venom was carried out
using the SPOT method. A set of overlapping peptides (15 residues,
frameshifted by three residues) corresponding to the amino acid
sequences of four different 3FTx (Mcor100c, Mcor0039c,
Mcor0064c and Mcor599c) and of a representative PLA2 was
prepared.
The binding pattern of three different anti-elapidic antivenoms
with overlapping peptides from the four 3FTX is shown in Fig. 1A,
and with peptides from PLA2 in Fig. 2A. Peptide recognition was
similar for the three sera, with variations in intensity. The reactivity
of the membranes was evaluated separately for each serum by
ImageJ software. A sum of the reactivities was made in order to
direct the choice of the common reactive regions within each toxin
for soluble peptide synthesis. Fig. 1B (for 3FTX) and Fig. 2B (for
PLA2) show the binding intensity and the sum of reactivities,
correlating with a gray scale.
Fig. 1C shows the alignment of the four 3FTX. The most reactive
regions detected by the SPOT method are highlighted in gray. The
program EPITOPIA, which evaluates the immunogenic potential of
residues in protein sequences, was also used as another method to
map epitope regions in these toxins. Residues with higher immu-
nogenic potential score are shown in red.
Considering the two analyses, two sequences from each toxin,
comprising the most reactive regions and the higher number of
potentially immunogenic residues, were chosen as epitopes and
the corresponding peptide sequences were synthesized. The se-
quences were limited to 20 residues, due to technical constraints
of the synthesis, which could not assure high quality above this
length. The selected sequences are shown in red boxes (Fig. 1C).
From the 3FTX Mcor 0100c, only one sequence ﬁlled the choice
criteria (39PDDFTCVKKWEGGGRRV55), named Pep100. From
Mcor0599c, three SPOT-reactive regions were identiﬁed. To
encompass potentially immunogenic residues, two N-term regions
were combined and formed Pep599a (28RHASDSQTTTCLSGI-
CYKK45). The third region (58GCPQSSRGVKVDCCMRDK75) was
selected as Pep599b. From 3FTX Mcor0604c, the N-term region
was selected as Pep604a (22LECKICNFKTCPTDELRH39). A second
region identiﬁed by the SPOT-method was shifted 10 residues
towards the N-term to comprise a region rich in immunogenic
residues predicted by EPITOPIA (54THRGLRIDRGCAATCPTVK72),
named and Pep604b. From 3FTX Mcor0039c, two regions identi-
ﬁed by SPOT overlapped. The N-term of this region formed
Pep039a (37TCPAGQKICFKKWKKG52) and the C-term, shifted by
seven residues towards the C-term of the toxin to comprise
immunogenic residues, originated Pep039b (64PKPKKDETIQCC
TKNN79).
Fig. 1. B cell epitope analysis of 3FTX fromM. corallinus venom. (A) Cellulose membrane containing 15mer overlapping peptides from 3FTX (Mcor0039c, Mcor0100c, Mcor0599c
and Mcor 00604c) tested with anti-elapidic sera from IB (1:10,000 dilution), FUNED (1:10,000 dilution) or rabbit sera anti-M. corallinus venom (1:2000 dilution). (B) The reaction of
each individual spot with the three different sera was quantiﬁed by ImageJ. The intensity is represented in different shades of gray, and a score of reactivity was given to the
combination of the three reactions (þ). The sequence corresponding to each spot is also represented. (C) The fourM. corallinus 3FTX sequences were aligned using the tool ClustalW
(Larkin et al., 2007). The signal peptide is shown in an identiﬁed box. The regions that showed highest reactivity by the SPOT method are highlighted in gray. Residues shown in red
are those with higher score in the immunogenicity scale by the prediction made by EPITOPIA. Using both SPOT and EPITOPIA analysis, sequences (red boxes) were selected to
represent epitopes. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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Four regions were identiﬁed by the SPOT-method for this toxin. The
selected regions were those which presented a higher sum of
reactivity by this method: 28NLINFQRMIQCTTRRSAW45 and
119NCDRTAALCFGRAPYNKNN137, named PepPLA2a and PepPLA2b,
respectively.
Since the three dimensional structure of the studied toxins were
not available, models were obtained by homology modeling. The
atomic coordinates of Bucain (PDB ID 2H8UA, Murakami, M.T.; Kini
R.M.; Arni, R.K.) from the Bungarus candidus, obtained by X-ray
crystallography, was used for modeling the 3FTX, and for the PLA2
model, the structure of the acid phospholipase A2 from Ophio-
phagus hannah (PDB ID 1gp7, Zhang, H et al., 2002) was used. Inorder to verify the localization of the selected epitopes, the corre-
sponding peptides were highlighted in red and blue, in the
modeled three-dimensional structures of its parent toxin (Fig. 3A-
Mcor0100; B- Mcor0039; C- Mcor 0609; D- Mcor0599; E- Mcor-
PLA2). Peptides A are shown in red and peptides B in blue.
3.2. Characterization of B-cell epitopes
Indirect ELISA was used to evaluate the antigenic/immunogenic
characteristics of the peptides previously deﬁned as epitopes.
Microplates were coated with M. corallinus venom. The anti-
peptide antibodies present in the sera withdrawn after the ﬁrst
six doses from the ﬁrst cycle did not react withM. corallinus venom.
Fig. 1. (continued).
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second cycle, showed a high reactivity (Fig. 4A). Rabbit sera reac-
tivity was also evaluated against the glutaradehyde polymerized
peptides (Fig. 4B). The reaction of the sera obtained after the 1stand 2nd cycle were analyzed by ELISA, with each of the nine
selected polymerized peptides separately. After the second cycle,
all peptides (except for Pep39a and PepPLA2b) showed high reac-
tivity with the anti-peptide antibodies. After the last dose, IgGs
Fig. 2. B cell epitope analysis of PLA2 from M. corallinus venom. (A) Cellulose membrane containing 15mer overlapping peptides from McorPLA2 was tested with either anti-
elapidic sera from IB (1:10,000 dilution), FUNED (1:10,000 dilution) or rabbit sera anti-M. corallinus venom (1:2000 dilution). (B) The reaction of each individual spot was quantiﬁed
by ImageJ for each sera tested. The intensity is represented in different shades of gray, and a score of reactivity was given to the combination of the three reactions (þ). The sequence
corresponding to each spot is also represented. (C) Sequence from McorPLA2. The signal peptide is shown in an identiﬁed box. The most reactive regions by SPOT are highlighted in
gray. Residues shown in red were those who had the highest score in the immunogenicity scale by the prediction made by EPITOPIA. Using both SPOT and EPITOPES analyses, the
sequences (red boxes) were selected to represent epitopes. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
K.L. Castro et al. / Toxicon 93 (2015) 51e6056were puriﬁed from the pre immune and immune sera. Their cross-
reactivity against other Micrurus species was evaluated (Fig. 5). In
addition to the already expected high reactivity of the anti-peptide
sera against M. corallinus venom, it also showed cross reactivity
against M. frontalis and M. lemniscatus.
The minimum phospholipasic dose (MPD) of M. corallinus
venom was examined through an indirect hemolytic assay
(Gutierrez et al., 1988) and deﬁned as 1.84 mg of crude venom. To
analyze the capacity of IgGs anti-peptides to neutralize PLA2 ac-
tivity, different dilutions of the IgGs were incubated with 1 MPD
of M. corallinus venom. The mixture was pipetted into the agar
plate containing erythrocytes, egg yolk (as source of lecithin) and
CaCl2. After 18 h of incubation, the inhibition halos here measured.
Three micrograms of puriﬁed anti-peptide IgG were able of
neutralizing 100% of the MPD of M. corallinus venom. Pre-immune
rabbit IgG incubated with the venoms was used as control (Fig. 6A,
Cþ) and did not show any neutralizing properties. PBS incubated
with IgGs alone was not able to produce a detectable halo (Fig. 6A,
C).
The capacity of the anti-peptides antibodies from immunized
rabbits to neutralize M. corallinus soluble venom was determined
by in vivo neutralization assays. A dose corresponding to 1.5 DL50
(10.5 mg, according to Tanaka et al., 2010) of M. corallinus was pre-
incubated with 100 ml of PBS, as a negative control, FUNED anti-elapidic antivenom, as a positive control, anti-M. corallinus rabbit
sera or anti-peptide sera. The results of these experiments are re-
ported in Table 1 and show that a 50% protection against a chal-
lenge by a lethal dose of M. corallinus crude venoms has been
obtained by immunization with the peptide mixture.
4. Discussion
The genus Micrurus sp is responsible for only 0.6% (0.09 cases/
100,000 inhabitants) of all snakebites recorded yearly in Brazil, but
the majority of the accidents are considered severe and anti-venom
administration is recommended primarily in all cases (Ministerio
da Saúde do Brasil, 2014). Despite the clinical success of passively
administered coral snake therapeutic anti-venom, the production
and quality control of these anti-venoms are limited, due to the
difﬁculty in obtaining a desirable amount of venom. As a possible
alternative to solve this problem, native or recombinant protein
components can be used for the production of antibodies against
Micrurus venoms (Le~ao et al., 2009). However, immunization of
animals with active proteins remains a question to be addressed,
due to the highly lethal or toxic character of the immunogens and
the antigenic diversity present in it. The development of a new
generation of therapeutic anti-venoms by the precise identiﬁcation
of linear or conformational epitopes directed to the production of
Fig. 3. Spatial localization of the selected sequences in the modeled 3D structure of toxins. (A) Mcor0100c, Pep100 (red); (B) Mcor0039c, Pep39a (red) and Pep39b (blue); (C)
Mcor0604c, Pep604a (red) and Pep604b (blue); (D) Mcor0599c, Pep599a (red) Pep599b (blue); (E) McorPLA2, PepPLA2a (red) and PepPLA2b (blue). (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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perspective in the Toxinology ﬁeld (Mendes et al., 2013).
Since 3FTx and PLA2 are highly abundant components in Ela-
pidic venom (Corre^a-Netto et al., 2001), are the major responsible
for the envenoming process by M. corallinus and yet capable of
inducing polyclonal antibodies (Le~ao et al., 2009), theywere chosen
for the identiﬁcation of functional B-cell linear epitopes using the
SPOT synthesis and EPITOPIA methods (Frank, 2002, Rubinstein
et al., 2009). Using SPOT, we measured the ability of anti-
M. corallinus crude venom antibodies, elicited in two different an-
imal species, to bind to a set of immobilized overlapping peptides of
uniform size, covering the complete amino acid sequence of four
3TFX and a representative PLA2. Using experimental and in silico
approaches, it was possible to make a reasonable choice and two
different antigenic regions were disclosed in all toxins analyzed,
with the exception of the 3FTX Mcor100c, with only one region
ﬁlling up the choice criteria. The number of predicted epitopes in
this work is in agreement with previous works, which predicted
epitopes in small polypeptides as neurotoxins or myotoxins from
scorpion and snake venoms (Chavez-Olortegui et al., 2002;
Lomonte, 2012).The nine deﬁned epitopes were chemically synthesized in a
soluble form and together used as immunogens to rabbits with
Freund's and Montanide adjuvants. The antibody response of each
immunized rabbit against the synthetic peptides and against crude
M. corallinus venomwas evaluated by ELISA. Through these assays,
after the second cycle of immunization, wewere capable to detect a
strong antibody response of the immunized rabbits' sera against
M. corallinus crude venom. The low reactivity observed during the
ﬁrst cycle of immunization was not surprising, since the used
immunogen was a mixture of small-length peptides that cannot
strongly stimulate the immune system.
We observed that a single peptide from Mcor0039c (Pep039b)
and of PLA2 (PepPLA2a) elicited a strong antibody responsewhereas
Pep039a from Mcor0039c and pepPLA2b from McorPLA2 appar-
ently were not immunogenic, using ELISA as a detectionmethod for
the produced antibodies. All of the other peptides fromMcor0100c,
Mcor0599c and Mcor 00604c were immunogenic in rabbits.
The antibody response was found to be cross-reactive, since it
was possible to detect by ELISA circulating antibodies against
M. frontalis and M. lemniscatus crude venoms, that together with
M. corallinus are the species responsible for the majority of the
Fig. 4. ELISA characterization of the anti-peptide rabbit antibodies against M. corallines venom and synthetic peptides. (A) Reactivity of the anti-peptide rabbit sera against
M. corallinus venom, after each immunization dose. Plates were coated with 100 ml of venom (5 mg/ml). Pre-immune and anti-M. corallinus rabbit sera (diluted 1:500) were used as
controls. (B) Reactivity of the anti-peptide rabbit sera (diluted at 1:100), withdrawn after the end of each immunization cycle, against individual peptides. ELISA plates were coated
with 100 ml (10 mg/ml) of polymerized peptides. Values are means ±SEM of duplicates.
Fig. 5. Cross-reactivity of anti-peptide antibodies by ELISA. ELISA showing the re-
action of rabbit IgG anti-peptides against coral snake venoms (M. corallinus,M. frontalis
and M. lemniscatus). ELISA plates were coated with 5 mg/ml solution of each venom.
IgGs were tested at ﬁve different concentrations. The absorbance of the samples was
determined at 490 nm. Values are means ±SEM of duplicates.
K.L. Castro et al. / Toxicon 93 (2015) 51e6058accidents in Brazil (Ciscotto et al., 2011). The cross-reactivity of
humoral response might be an interesting point for studies in
therapeutic antivenom or vaccine development (Felicori et al.,
2010).
The percentage of inhibition of the phospholipase activity of
M. corallinus venom was assessed by pre-incubation with anti-
peptide antibodies, from the serum of immunized rabbits.
Amounts corresponding to 3 mg de IgG anti-peptides inhibit 100% of
the phospholipase activity of a quantity of 1.84 mg of crude
M. corallinus venom, which corresponds to one MPD, the minor
concentration of venom which produced a 1 cm diameter hemo-
lytic halo. The lethal activity neutralization of different sera (pre-
immune, commercial antivenom produced in Brazil, rabbit anti-
venom against M. corallinus and anti-peptides antibodies) was
compared. The in vivo neutralization assay was performed in non-
immunized mice by pre-incubating 1.5 LD50 ofM. corallinus venom
with 100 ml of the antivenoms. Both anti-Micrurus anti-venoms
were able to neutralize about 100% of lethal activity, and 50% of
protection was detected in the group of mice that received anti-
peptide antibodies. Mice from control group, that received venom
in PBS, did not show any protection.
The use of multiple epitopes representing complex venoms to
obtain neutralizing sera has already been attempted. Wagstaff andco-workers, in 2006 engineered seven epitopes, predicted by bio-
informatics tools, to represent the variety of metalloproteases
present in the African snake Echis occelatus venom as a single
synthetic DNA immunogen, which they called epitope string. The
Fig. 6. Neutralization of phospholipase activity of M. corallinus venom by IgGs anti-peptides. (A) Indirect hemolytic assay, using 1MPD of M. corallinus venom incubated with
different amounts of anti-peptide IgG. Pre immune IgG (6 mg) incubated with venom (1MPD) was used as a positive control (Cþ) and IgG incubated with PBS instead of venomwas
used as negative control (C-). (B) The percentage of PLA2 activity inhibition was measured considering the halo of 100 mm as the maximum. The results are means ±SEM of
duplicates.
Table 1
In vivo protection of anti-peptide sera. Amounts of M. corallinus venom, corre-
sponding to 1.5 DL50 were incubated with 100 ml of either PBS, commercial anti-
Micrurus antivenom, anti-M. corallinus rabbit sera or anti-peptide rabbit sera.
M. corallinus (1.5 DL50)
Death/injected ratio % death
C (PBS) 4/4 100
Cþ (FUNED Antivenom) 0/4 0
a M. corallinus 0/4 0
a Peptides 2/4 50
K.L. Castro et al. / Toxicon 93 (2015) 51e60 59produced antivenom was capable of neutralizing hemorrhage
caused by E. occelatus venom and Cerastes cerastes as well, indica-
tion an important cross-reactivity of the antivenom (Wagstaff et al.,
2006). Our group has also recently engineered, by molecular
biology techniques, a chimeric protein composed by validated
epitopes from a dermonecrotic protein present in the spider Lox-
osceles intermedia venom. Using a rabbit model, preincubation of
anti-chimeric protein serumwas capable of neutralizing 95% of the
dermonecrotic activity of the recombinant toxin (Mendes et al.,
2013). This chimeric protein was further used, in combined proto-
col with crude venom (3 doses of venom and 9 doses of chimeric
protein), to immunize horses (Figueiredo et al., 2014). The obtained
sera had neutralization properties similar to traditional antivenom
and spared the use of crude venom in 67%.
Taken together, the previous publications and the present work
indicate that the use of molecules mimicking multiple epitopes is
an efﬁcient approach for antivenom production. Our results pro-
vide a rational basis to the identiﬁcation of neutralizing epitopes on
coral snake toxins and show that their corresponding synthetic
peptides could improve the generation of immunotherapeutics
against coral snakes venoms. The use of synthetic peptide for im-
munization is a reasonable approach, since it enables poly speci-
ﬁcity, low risk of toxic effects and large scale production.Acknowledgments
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